Actively Recruiting
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Led by Bernardino Clavo, MD, PhD · Updated on 2025-09-02
105
Participants Needed
1
Research Sites
210 weeks
Total Duration
On this page
Sponsors
B
Bernardino Clavo, MD, PhD
Lead Sponsor
F
Fundación Canaria Instituto de Investigación Sanitaria de Canarias
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main objective of this study is to analyze the impact on the health-related quality of life of patients with refractory symptoms, who have been referred to the HUGCDN Chronic Pain Unit for adjuvant palliative treatment with ozone therapy between June-2022 and December-2025
CONDITIONS
Official Title
Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2022 and 2025
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years old or older
- Referred to the Chronic Pain Unit for palliative ozone therapy due to lack of effective standard treatment, treatment failure, or high risk/morbidity with standard treatment
- Potential benefit expected from adding ozone therapy to current treatment
- No contraindications for ozone therapy
- Signed informed consent for compassionate ozone treatment and study participation
You will not qualify if you...
- Younger than 18 years old
- Psychiatric illness or social situations limiting study compliance
- Unable to complete required questionnaires or scales
- Hemodynamically or clinically unstable or have uncontrolled severe illness
- Uncontrolled cancer requiring chemotherapy
- Life expectancy less than 6 months
- Contraindications or inability to attend scheduled treatments
- Known allergy to ozone
- Pregnant at enrollment (for systemic ozone therapy)
- Hemochromatosis (for systemic ozone therapy)
- Significant glucose-6-phosphate dehydrogenase deficiency (for systemic ozone therapy)
- Failure to meet all inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dr. Negrín University Hospital
Las Palmas, Las Palmas, Spain, 35019
Actively Recruiting
Research Team
B
Bernardino Clavo, MD, PhyD
CONTACT
F
Francisco Rodríguez-Esparragón, BSci, PhyD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here